Expanding access to medications for opioid use disorder through pharmacist scope-of-practice flexibility
Journal of the American Pharmacists Association · 2026-11 · 66 (6) · 103522
DOI: 10.1016/j.japh.2026.103522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-11. Verfasst von Alex J Adams. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Pharmacists, Health Services Accessibility, Community Pharmacy Services. Die Arbeit nennt 13 Literaturangaben.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Opioid use disorder (OUD) is a treatable chronic disease, yet access to medications for OUD remains uneven, particularly in rural and underserved communities where prescriber shortages, travel burdens, and restrictive scope-of-practice laws can delay care. Community pharmacists are highly accessible medication experts who already monitor therapy, counsel patients, identify safety concerns, and coordinate care. States should consider authorizing pharmacists to initiate or prescribe medications for OUD, consistent with federal authority and established standards of care. Pharmacy-based care models suggest that this approach can shorten treatment delays and strengthen continuity while supporting individualized care throughout recovery. Expanded pharmacist authority also has implications beyond health care: untreated parental OUD contributes to child welfare involvement, and timely treatment can help stabilize families and prevent unnecessary separation. Recent federal guidance, Title IV-E financing pathways, and the Rural Health Transformation Program give states tools to align pharmacy regulation, Medicaid payment, behavioral health systems, and child welfare policy. Removing unnecessary barriers to pharmacist prescribing could expand the treatment workforce, improve access close to home, and make evidence-based care available when patients are ready to begin recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Adams, A. J. (2026). Expanding access to medications for opioid use disorder through pharmacist scope-of-practice flexibility. Journal of the American Pharmacists Association, 66(6), 103522. https://doi.org/10.1016/j.japh.2026.103522
Vancouver
Adams AJ. Expanding access to medications for opioid use disorder through pharmacist scope-of-practice flexibility. Journal of the American Pharmacists Association. 2026;66(6):103522. doi:10.1016/j.japh.2026.103522
BibTeX
@article{Adams2026,
author = {Adams, Alex J},
title = {Expanding access to medications for opioid use disorder through pharmacist scope-of-practice flexibility},
journal = {Journal of the American Pharmacists Association},
year = {2026},
volume = {66},
number = {6},
pages = {103522},
doi = {10.1016/j.japh.2026.103522}
}
EUVIMED